Food and Drug Administration

FDA Reviews Safety of Food Preservative BHA

FDA moves to ban BHA — an additive used in processed foods such as meats and bread

The Food and Drug Administration on Tuesday took steps toward banning BHA, a food additive used in processed foods such as meats and bread.

· 2d

FDA Opens Safety Review of Synthetic Food Preservative BHA (1)

· 1d

Is your food safe? FDA reviews popular preservative over cancer risks

FDA won't consider a new mRNA vaccine for flu

Digest more

· 23h

FDA Declines to Review Moderna’s mRNA Flu Vaccine Application

In a major blow to vaccine development, the U.S. Food and Drug Administration (FDA) said it will not review Moderna’s application for the first mRNA-based flu shot. Dr. Vinay Prasad, the nation’s top vaccine regulator,

· 1d

FDA officials defend decision to not review Moderna’s new flu vaccine

· 1h

FDA refuses to consider Moderna flu shot in move experts claim is part of ‘anti-vaccine agenda’

· 1d

Moderna says FDA won't review its mRNA flu shot | Morning in America

The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday.

· 15h

FDA defends its decision to refuse review of Moderna's flu vaccine

· 1d

FDA Refuses to Review Moderna's mRNA Flu Shot

2don MSN

US FDA to review decades-old food preservative in safety overhaul

Feb 10 (Reuters) - The U.S. Food and Drug Administration on Tuesday launched a broad review of a long-used synthetic preservative used in packaged foods, as the agency steps up efforts to reassess chemicals long allowed in the U.

FDA moves to stop non-approved GLP-1 drugs

The U.S. Food and Drug Administration (FDA) plans to take steps to limit the use of GLP-1 in non-FDA-approved compounded drugs. According to a press release, the FDA is

Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna has requested a Type A meeting to understand the path forward

FDA Reviews Safety of Food Preservative BHA

FDA won't consider a new mRNA vaccine for flu

US FDA to review decades-old food preservative in safety overhaul

FDA moves to stop non-approved GLP-1 drugs

Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

House lawmaker raises new concerns over FDA's ultra-fast drug review program

FDA clarifies rules for “no artificial colours” food packaging claims

FDA Loosens Rules for ‘No Artificial Colors’ Labeling on Food